376 related articles for article (PubMed ID: 8850425)
1. In vitro determination of toxicity, binding, retention, subcellular distribution and biological efficacy of the boron neutron capture agent DAC-1.
Tilly N; Olsson P; Hartman T; Coderre J; Makar M; Malmquist J; Sjöberg S; Pettersson J; Carlsson J; Glimelius B
Radiother Oncol; 1996 Jan; 38(1):41-50. PubMed ID: 8850425
[TBL] [Abstract][Full Text] [Related]
2. Uptake, toxicity and radiation effects of the boron compounds DAAC-1 and DAC-1 in cultured human glioma cells.
Olsson P; Black M; Capala J; Coderre J; Hartman T; Makar M; Malmquist J; Pettersson J; Tilly N; Sjöberg S; Carlsson J
Int J Radiat Biol; 1998 Jan; 73(1):103-12. PubMed ID: 9464482
[TBL] [Abstract][Full Text] [Related]
3. New carborane-based compounds for boron neutron capture therapy: binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells.
Lindström P; Olsson P; Malmqvist J; Pettersson J; Lemmen P; Werner B; Sjöberg S; Olin A; Carlsson J
Anticancer Drugs; 1994 Feb; 5(1):43-52. PubMed ID: 8186429
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo simulation of the biological effects of boron neutron capture irradiation with d(14)+Be neutrons in vitro.
Pöller F; Sauerwein W
Radiat Res; 1995 Apr; 142(1):98-106. PubMed ID: 7899565
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
6. A Model for Estimating Dose-Rate Effects on Cell-Killing of Human Melanoma after Boron Neutron Capture Therapy.
Matsuya Y; Fukunaga H; Omura M; Date H
Cells; 2020 Apr; 9(5):. PubMed ID: 32365916
[TBL] [Abstract][Full Text] [Related]
7. Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy.
Hartman T; Carlsson J
Radiother Oncol; 1994 Apr; 31(1):61-75. PubMed ID: 8041899
[TBL] [Abstract][Full Text] [Related]
8. Boron neutron capture therapy (BNCT): implications of neutron beam and boron compound characteristics.
Wheeler FJ; Nigg DW; Capala J; Watkins PR; Vroegindeweij C; Auterinen I; Seppälä T; Bleuel D
Med Phys; 1999 Jul; 26(7):1237-44. PubMed ID: 10435523
[TBL] [Abstract][Full Text] [Related]
9. Monte Carlo based protocol for cell survival and tumour control probability in BNCT.
Ye SJ
Phys Med Biol; 1999 Feb; 44(2):447-61. PubMed ID: 10070794
[TBL] [Abstract][Full Text] [Related]
10. Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.
Wang P; Zhen H; Jiang X; Zhang W; Cheng X; Guo G; Mao X; Zhang X
BMC Cancer; 2010 Dec; 10():661. PubMed ID: 21122152
[TBL] [Abstract][Full Text] [Related]
11. Computational assessment of deep-seated tumor treatment capability of the 9Be(d,n)10B reaction for accelerator-based boron neutron capture therapy (AB-BNCT).
Capoulat ME; Minsky DM; Kreiner AJ
Phys Med; 2014 Mar; 30(2):133-46. PubMed ID: 23880544
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of the high-LET radiations from the boron neutron capture [10B(n,α) 7Li] reaction determined for induction of chromosome aberrations and apoptosis in lymphocytes of human blood samples.
Schmid TE; Canella L; Kudejova P; Wagner FM; Röhrmoser A; Schmid E
Radiat Environ Biophys; 2015 Mar; 54(1):91-102. PubMed ID: 25428113
[TBL] [Abstract][Full Text] [Related]
13. Derivations of relative biological effectiveness for the high-let radiations produced during boron neutron capture irradiations of the 9L rat gliosarcoma in vitro and in vivo.
Coderre JA; Makar MS; Micca PL; Nawrocky MM; Liu HB; Joel DD; Slatkin DN; Amols HI
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1121-9. PubMed ID: 8262837
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of boron compounds to tumor with polyethylene-glycol binding liposome by using neutron capture autoradiography.
Yanagië H; Ogura K; Takagi K; Maruyama K; Matsumoto T; Sakurai Y; Skvarc J; Illic R; Kuhne G; Hisa T; Yoshizaki I; Kono K; Furuya Y; Sugiyama H; Kobayashi H; Ono K; Nakagawa K; Eriguchi M
Appl Radiat Isot; 2004 Oct; 61(4):639-46. PubMed ID: 15246411
[TBL] [Abstract][Full Text] [Related]
15. Porphyrin-mediated boron neutron capture therapy: a preclinical evaluation of the response of the oral mucosa.
Morris GM; Coderre JA; Micca PL; Nawrocky MM; Hopewell JW; Miura M
Radiat Res; 2005 Jan; 163(1):72-8. PubMed ID: 15606309
[TBL] [Abstract][Full Text] [Related]
16. On-line reconstruction of low boron concentrations by in vivo gamma-ray spectroscopy for BNCT.
Verbakel WF; Stecher-Rasmussen F
Phys Med Biol; 2001 Mar; 46(3):687-701. PubMed ID: 11277217
[TBL] [Abstract][Full Text] [Related]
17. Comet assay study of DNA damage and repair of tumour cells following boron neutron capture irradiation with fast d(14) + Be neutrons.
Pöller F; Bauch T; Sauerwein W; Böcker W; Wittig A; Streffer C
Int J Radiat Biol; 1996 Nov; 70(5):593-602. PubMed ID: 8947541
[TBL] [Abstract][Full Text] [Related]
18. Development of a dual phantom technique for measuring the fast neutron component of dose in boron neutron capture therapy.
Sakurai Y; Tanaka H; Kondo N; Kinashi Y; Suzuki M; Masunaga S; Ono K; Maruhashi A
Med Phys; 2015 Nov; 42(11):6651-7. PubMed ID: 26520755
[TBL] [Abstract][Full Text] [Related]
19. Dose enhancement in fast neutron tumour therapy due to neutron captures in 10B.
Carlsson J; Hartman T; Grusell E
Acta Oncol; 1994; 33(3):315-22. PubMed ID: 8018361
[TBL] [Abstract][Full Text] [Related]
20. Influence of Neutron Sources and 10B Concentration on Boron Neutron Capture Therapy for Shallow and Deeper Non-small Cell Lung Cancer.
Yu H; Tang X; Shu D; Liu Y; Geng C; Gong C; Hang S; Chen D
Health Phys; 2017 Mar; 112(3):258-265. PubMed ID: 28121726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
